Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Center for CytoGenetics, Inc. was a private clinical laboratory and contract research organization (CRO) based in Nashville, Tennessee, that specialized in genetic and molecular testing services. The company provided a comprehensive suite of diagnostic tools, including chromosome analysis (cytogenetics), fluorescence in situ hybridization (FISH), and flow cytometry, primarily focused on cancer diagnosis and genetic screening. In April 2006, the company was acquired by NeoGenomics, Inc., a leading provider of oncology-focused genetic testing, to serve as a regional laboratory hub and expand its service footprint in the southeastern United States. The integration allowed NeoGenomics to leverage the center's specialized expertise and laboratory facilities to improve turnaround times for regional clients in the rapidly growing field of personalized medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Cytogenetics.